Literature DB >> 26131233

Patients with polycystic ovary syndrome have successful embryo arrest.

Baoli Yin1, Haoying Hao1, Duo Wei1, Xiaobing Song1, Juanke Xie1, Cuilian Zhang1.   

Abstract

In this retrospective study, we investigate the relationship between embryo arrest and polycystic ovary syndrome (PCOS) during in vitro fertilization-embryo transfer (IVF-ET). In this study, 667 subjects were enrolled, including 330 patients with PCOS and 337 subjects without PCOS. The subjects underwent in vitro fertilization/intracytoplasmic sperm injection and embryo transfer (IVF/ICSI-ET) cycles at the Reproductive Medical Centre of Henan Provincial Hospital from January 2009 to December 2012. Four protocols were used to stimulate the ovaries, including long protocol, super-long down-regulation protocol, short protocol and antagonist protocol. Oocytes were retrieved using transvaginal ultrasound guidance. Pronuclei were checked on the next morning after IVF/ICSI. Cleavage stage embryo was assessed after 62-66 hours. Women with PCOS had significantly elevated body mass index, basal luteinizing hormone, estradiol and testosterone compared with normal women. Basal Follicle stimulating hormone level in PCOS patients was lower compared with that in control group. After IVF-ET, PCOS patients had more available oocytes than subjects in control group. PCOS patients had slightly lower fertilization rate than the controls in IVF cycles, but in ICSI cycles, fertilization rate in PCOS patients was significantly higher than that in controls. For either IVF or ICSI, the embryo arrest rate was not changed by PCOS. Moreover, there was no significant difference in embryo arrest rate between both groups adopting different stimulation protocols. Interestingly, embryo arrest rate was not correlated with testosterone for patients in PCOS group. The data indicated that patients with PCOS had successful early embryo arrest during IVF-ET.

Entities:  

Keywords:  Polycystic ovary syndrome; embryo arrest; embryo transfer; in vitro fertilization; intracytoplasmic sperm injection; testosterone

Year:  2015        PMID: 26131233      PMCID: PMC4484026     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  26 in total

Review 1.  Genetic regulation of embryo death and senescence.

Authors:  D H Betts; W A King
Journal:  Theriogenology       Date:  2001-01-01       Impact factor: 2.740

2.  The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome.

Authors:  K Sengoku; K Tamate; N Takuma; T Yoshida; K Goishi; M Ishikawa
Journal:  Hum Reprod       Date:  1997-03       Impact factor: 6.918

3.  Analysis of apoptosis in the preimplantation bovine embryo using TUNEL.

Authors:  A T Byrne; J Southgate; D R Brison; H J Leese
Journal:  J Reprod Fertil       Date:  1999-09

4.  Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors.

Authors:  L A Stadtmauer; S K Toma; R M Riehl; L M Talbert
Journal:  Fertil Steril       Date:  2001-03       Impact factor: 7.329

5.  Apoptosis in the early bovine embryo.

Authors:  C Matwee; D H Betts; W A King
Journal:  Zygote       Date:  2000-02       Impact factor: 1.442

6.  A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins.

Authors:  R Marci; A Senn; S Dessole; A Chanson; E Loumaye; P De Grandi; M Germond
Journal:  Fertil Steril       Date:  2001-06       Impact factor: 7.329

Review 7.  Role of reactive oxygen species in the pathophysiology of human reproduction.

Authors:  Ashok Agarwal; Ramadan A Saleh; Mohamed A Bedaiwy
Journal:  Fertil Steril       Date:  2003-04       Impact factor: 7.329

8.  A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization.

Authors:  M J MacDougall; S L Tan; A Balen; H S Jacobs
Journal:  Hum Reprod       Date:  1993-02       Impact factor: 6.918

9.  High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome.

Authors:  H Kodama; J Fukuda; H Karube; T Matsui; Y Shimizu; T Tanaka
Journal:  Hum Reprod       Date:  1995-08       Impact factor: 6.918

Review 10.  Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.

Authors:  Jie Qiao; Huai L Feng
Journal:  Hum Reprod Update       Date:  2010-07-16       Impact factor: 15.610

View more
  4 in total

1.  Competence of embryos showing transient developmental arrest during in vitro culture.

Authors:  Debbie Montjean; Cendrine Geoffroy-Siraudin; Marie-José Gervoise-Boyer; Pierre Boyer
Journal:  J Assist Reprod Genet       Date:  2021-02-02       Impact factor: 3.412

Review 2.  Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques-A Literature Review.

Authors:  Enrique Reyes-Muñoz; Thozhukat Sathyapalan; Paola Rossetti; Mohsin Shah; Min Long; Massimo Buscema; Gaetano Valenti; Valentina Lucia La Rosa; Stefano Cianci; Salvatore Giovanni Vitale
Journal:  Adv Ther       Date:  2018-10-11       Impact factor: 3.845

3.  The effect of curcumin on embryonic in vitro development in experimental polycystic ovary syndrome: An experimental study.

Authors:  Yousef Nasiri Bari; Vahab Babapour; Abbas Ahmadi; Morteza Zendehdel Kheybari; Ghasem Akbari
Journal:  Int J Reprod Biomed       Date:  2021-12-13

4.  Effects of Negative Emotions and Life Events on Women's Missed Miscarriage.

Authors:  Huilin Xing; Yaping Luo; Shouying Wang
Journal:  Iran J Public Health       Date:  2018-02       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.